$DVAX Headlines
Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
FDA: Dynavax hep B vaccine needs more evaluation 6:49 a.m. Feb. 25, 2013 - MarketWatch.com
Dynavax Tech down 14% in premarket 7:51 a.m. Dec. 3, 2012 - Steve Gelsi
Dynavax Tech off 17% in premarket trades 7:38 a.m. Nov. 29, 2012 - Steve Gelsi
Dynavax Tech falls 49% in premarket trades 8:42 a.m. Nov. 16, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 1:42 p.m. May 9, 2012 - MarketWatch
Dynavax tumbles 24% on stock offer pricing 11:05 a.m. May 9, 2012 - Val Brickates Kennedy
Dynavax jumps 25% on FDA update 8:45 a.m. July 28, 2011 - Val Brickates Kennedy
Dynavax plunges 16% on mixed study results 10:26 a.m. July 20, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:57 p.m. Sept. 21, 2010 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:43 p.m. Nov. 10, 2009 - MarketWatch
Dynavax to buy Symphony Dynamo 7:00 a.m. Nov. 10, 2009 - William L. Watts
Symphony to own 24% of Dynavax 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to issue 13 million shares 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to buy Symphony Dynamo 6:48 a.m. Nov. 10, 2009 - Steve Goldstein
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Dynavax retrenches; drug stocks mixed 1:18 p.m. Sept. 11, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy
Dynavax Submits Response to EMA - Analyst Blog 12:10 p.m. Dec. 24, 2013 - Zacks.com
Make Or Break Catalysts Approaching For Dynavax 8:28 a.m. Dec. 24, 2013 - Seeking Alpha
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals 3:33 a.m. Dec. 19, 2013 - Seeking Alpha
Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2% - Tale of the Tape 9:18 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Getting Ultra-Bullish On Dynavax 6:56 a.m. Nov. 18, 2013 - Seeking Alpha
Dynavax Technologies: 6 Reasons To Buy 11:24 a.m. Nov. 17, 2013 - Seeking Alpha
Insiders Are Buying These Speculative Biotech Stocks 10:05 a.m. Nov. 11, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial 7:44 a.m. Nov. 8, 2013 - benzinga.com
Top Three Largest Insider Buys of the Past Week 4:41 p.m. Nov. 5, 2013 - GuruFocus.com
AGCO Corporation Director Buys 343K Shares and 4 Insider Buys to Note 8:10 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Insiders Are Buying Dynavax 3:11 p.m. Oct. 31, 2013 - Seeking Alpha
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV 4:00 a.m. Oct. 17, 2013 - Seeking Alpha
Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow 3:11 p.m. Oct. 16, 2013 - benzinga.com
Pipeline Progress at Dynavax - Analyst Blog 11:10 a.m. Oct. 15, 2013 - Zacks.com
Dynavax Initiates Phase I Trial In Its Asthma Program 8:19 a.m. Oct. 10, 2013 - Seeking Alpha
Some Speculative Biotechs Making Major Moves 12:36 p.m. Sept. 25, 2013 - Seeking Alpha
Data on Dynavax' Heplisav - Analyst Blog 11:00 a.m. Sept. 25, 2013 - Zacks.com
Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE 2:01 p.m. Sept. 24, 2013 - benzinga.com
Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan 8:00 a.m. Dec. 24, 2013 - PR Newswire
Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA 9:01 a.m. Dec. 19, 2013 - Marketwire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax 8:00 a.m. Dec. 5, 2013 - PR Newswire
Dynavax Announces Resignation of J. Tyler Martin From Board of Directors 4:46 p.m. Nov. 27, 2013 - Marketwire
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 25, 2013 - ACCESSWIRE
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Dynavax Reports Third Quarter 2013 Financial Results 5:10 p.m. Nov. 7, 2013 - Marketwire
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Dynavax Prices Public Offerings of Common Stock and Series B Convertible Preferred Stock 7:30 a.m. Oct. 25, 2013 - Marketwire
Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock 3:01 p.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: Teva Pharma Industries Ltd, Dynavax Technologies Corp., Covidien PLC, and Valeant Pharma Intl. Inc. 8:39 a.m. Oct. 24, 2013 - PR Newswire
Dynavax Reports on HEPLISAV(TM) Regulatory Path 4:09 p.m. Oct. 16, 2013 - Marketwire
Dynavax Initiates First Human Trial in Asthma Program 4:46 p.m. Oct. 9, 2013 - Marketwire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE 3:00 p.m. Sept. 24, 2013 - Marketwire
Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. 7:00 a.m. Aug. 28, 2013 - PR Newswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Dynavax Technologies Corporation 8:01 a.m. Aug. 16, 2013 - BusinessWire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Dynavax Technologies Corporation 9:54 p.m. Aug. 13, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Deadline of August 19, 2013 to Seek Lead Plaintiff Position 3:37 p.m. Aug. 12, 2013 - GlobeNewswire
Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
FDA: Dynavax hep B vaccine needs more evaluation 6:49 a.m. Feb. 25, 2013 - MarketWatch.com
Dynavax Tech down 14% in premarket 7:51 a.m. Dec. 3, 2012 - Steve Gelsi
Dynavax Tech off 17% in premarket trades 7:38 a.m. Nov. 29, 2012 - Steve Gelsi
Dynavax Tech falls 49% in premarket trades 8:42 a.m. Nov. 16, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 1:42 p.m. May 9, 2012 - MarketWatch
Dynavax tumbles 24% on stock offer pricing 11:05 a.m. May 9, 2012 - Val Brickates Kennedy
Dynavax jumps 25% on FDA update 8:45 a.m. July 28, 2011 - Val Brickates Kennedy
Dynavax plunges 16% on mixed study results 10:26 a.m. July 20, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:57 p.m. Sept. 21, 2010 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:43 p.m. Nov. 10, 2009 - MarketWatch
Dynavax to buy Symphony Dynamo 7:00 a.m. Nov. 10, 2009 - William L. Watts
Symphony to own 24% of Dynavax 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to issue 13 million shares 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to buy Symphony Dynamo 6:48 a.m. Nov. 10, 2009 - Steve Goldstein
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Dynavax retrenches; drug stocks mixed 1:18 p.m. Sept. 11, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy
Dynavax Submits Response to EMA - Analyst Blog 12:10 p.m. Dec. 24, 2013 - Zacks.com
Make Or Break Catalysts Approaching For Dynavax 8:28 a.m. Dec. 24, 2013 - Seeking Alpha
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals 3:33 a.m. Dec. 19, 2013 - Seeking Alpha
Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2% - Tale of the Tape 9:18 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Getting Ultra-Bullish On Dynavax 6:56 a.m. Nov. 18, 2013 - Seeking Alpha
Dynavax Technologies: 6 Reasons To Buy 11:24 a.m. Nov. 17, 2013 - Seeking Alpha
Insiders Are Buying These Speculative Biotech Stocks 10:05 a.m. Nov. 11, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial 7:44 a.m. Nov. 8, 2013 - benzinga.com
Top Three Largest Insider Buys of the Past Week 4:41 p.m. Nov. 5, 2013 - GuruFocus.com
AGCO Corporation Director Buys 343K Shares and 4 Insider Buys to Note 8:10 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Insiders Are Buying Dynavax 3:11 p.m. Oct. 31, 2013 - Seeking Alpha
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV 4:00 a.m. Oct. 17, 2013 - Seeking Alpha
Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow 3:11 p.m. Oct. 16, 2013 - benzinga.com
Pipeline Progress at Dynavax - Analyst Blog 11:10 a.m. Oct. 15, 2013 - Zacks.com
Dynavax Initiates Phase I Trial In Its Asthma Program 8:19 a.m. Oct. 10, 2013 - Seeking Alpha
Some Speculative Biotechs Making Major Moves 12:36 p.m. Sept. 25, 2013 - Seeking Alpha
Data on Dynavax' Heplisav - Analyst Blog 11:00 a.m. Sept. 25, 2013 - Zacks.com
Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE 2:01 p.m. Sept. 24, 2013 - benzinga.com
Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan 8:00 a.m. Dec. 24, 2013 - PR Newswire
Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA 9:01 a.m. Dec. 19, 2013 - Marketwire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax 8:00 a.m. Dec. 5, 2013 - PR Newswire
Dynavax Announces Resignation of J. Tyler Martin From Board of Directors 4:46 p.m. Nov. 27, 2013 - Marketwire
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 25, 2013 - ACCESSWIRE
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Dynavax Reports Third Quarter 2013 Financial Results 5:10 p.m. Nov. 7, 2013 - Marketwire
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Dynavax Prices Public Offerings of Common Stock and Series B Convertible Preferred Stock 7:30 a.m. Oct. 25, 2013 - Marketwire
Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock 3:01 p.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: Teva Pharma Industries Ltd, Dynavax Technologies Corp., Covidien PLC, and Valeant Pharma Intl. Inc. 8:39 a.m. Oct. 24, 2013 - PR Newswire
Dynavax Reports on HEPLISAV(TM) Regulatory Path 4:09 p.m. Oct. 16, 2013 - Marketwire
Dynavax Initiates First Human Trial in Asthma Program 4:46 p.m. Oct. 9, 2013 - Marketwire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE 3:00 p.m. Sept. 24, 2013 - Marketwire
Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. 7:00 a.m. Aug. 28, 2013 - PR Newswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Dynavax Technologies Corporation 8:01 a.m. Aug. 16, 2013 - BusinessWire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Dynavax Technologies Corporation 9:54 p.m. Aug. 13, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Deadline of August 19, 2013 to Seek Lead Plaintiff Position 3:37 p.m. Aug. 12, 2013 - GlobeNewswire
